As a buy side research associate/analyst in China/HK, do I ever have any exit opportunities back in the U.S.?

I'll be starting as a junior on the research team of a large U.S. AM firm based in China. I'll be working both on companies listed in China, and also Chinese companies listed abroad - mainly in HK and the U.S.

Will I ever have the chance to transition back to the states also in an AM/HF research role? If so, would it only be with specialized emerging markets funds? If it makes a difference, I invest in U.S. equities in my personal portfolio, but I obviously won't be touching those in my work.

I haven't decided yet whether it'll be worth the investment for me to spend the larger part of the beginning of my investment career specializing in China, when the outlook for the markets there is shaky at the moment. The pay is also not as good. I'm assuming this will change at some point, but the question is whether that'll be during my career.

Should I try to go back to the states asap assuming that the longer I spend in China, the harder it'll eventually be?

3 Comments
 

I'm assuming you're a Chinese national which is why your firm is sending you to China. If that's the case, I'd think the chance is not so great for you to get a transfer to the U.S. office of the same firm, which you can then use as a springboard to another U.S. AM/HF role. That said, you can always do an MBA in the U.S. (if you're a pre-MBA hire) and break in that way.

 

Omnis quo non laborum quae sint. Excepturi non ea mollitia officiis veniam ut incidunt natus. Voluptas officiis sed qui et et et et. Et et dolores officiis quod porro ut doloribus dolores.

Quia nam et omnis minima facilis minima. Ipsam laudantium dignissimos id repudiandae enim quo. Velit molestias sint nihil debitis ut. Rerum voluptatibus tenetur similique quod voluptatem dolor id. Quo iste impedit quia tempore repellat quia officia.

Accusamus et similique voluptate molestiae rerum qui. Officiis molestiae voluptatem asperiores soluta velit.

Deleniti accusamus repellendus qui animi in. Nihil odit sit cupiditate et placeat. Harum expedita sed qui officiis. A voluptatum aliquid sint ullam adipisci minus.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.2%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.7%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.2%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
GameTheory's picture
GameTheory
98.9
6
DrApeman's picture
DrApeman
98.9
7
dosk17's picture
dosk17
98.9
8
CompBanker's picture
CompBanker
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”